These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
82 related articles for article (PubMed ID: 6234834)
1. Pediatric oncology group utilization of immunologic markers in the designation of acute lymphocytic leukemia subgroups: influence on treatment response. Pullen DJ; Boyett JM; Crist WM; Falletta JM; Roper M; Dowell B; Van Eys J; Jackson JF; Humphrey GB; Metzgar RS Ann N Y Acad Sci; 1984; 428():26-48. PubMed ID: 6234834 [TBL] [Abstract][Full Text] [Related]
2. Southwest Oncology Group experience with immunological phenotyping in acute lymphocytic leukemia of childhood. Pullen DJ; Falletta JM; Crist WM; Vogler LB; Dowell B; Humphrey GB; Blackstock R; Eys JV; Cooper MD; Metzgar RS; Meydrech EF Cancer Res; 1981 Nov; 41(11 Pt 2):4802-9. PubMed ID: 6975163 [No Abstract] [Full Text] [Related]
3. Multimarker analysis of childhood acute lymphoblastic leukemia (ALL): heterogeneity of cellular phenotypes and clinical relevance of immunological defined ALL subclasses. Thoene I; Kabisch H Haematol Blood Transfus; 1983; 28():126-30. PubMed ID: 6574949 [No Abstract] [Full Text] [Related]
4. Prognostic factors in acute lymphoid leukaemia of childhood. II. Cell surface markers. Révész T; Walcz E; Keleti J; Kardos G; Zimonyi I; Kovács I; Kajtár P; Schuler D Acta Paediatr Hung; 1986; 27(4):295-301. PubMed ID: 2954566 [TBL] [Abstract][Full Text] [Related]
5. Quantitative variation of the common acute lymphoblastic leukemia antigen (gp100) on leukemic marrow blasts. Look AT; Melvin SL; Brown LK; Dockter ME; Roberson PK; Murphy SB J Clin Invest; 1984 Jun; 73(6):1617-28. PubMed ID: 6233301 [TBL] [Abstract][Full Text] [Related]
6. Definition of the high-risk acute lymphoblastic leukemia patient by immunological phenotyping with monoclonal antibodies. Zipf TF; Fox RI; Dilley J; Levy R Cancer Res; 1981 Nov; 41(11 Pt 2):4786-9. PubMed ID: 6975160 [TBL] [Abstract][Full Text] [Related]
7. [Cell surface markers of childhood leukemias and lymphomas]. Shibuya A; Shinozawa T; Yoshikawa T; Katayama I Rinsho Ketsueki; 1985 Jan; 26(1):7-14. PubMed ID: 3158761 [No Abstract] [Full Text] [Related]
8. [A case of acute leukemia with lympho- and myeloblastic blast cell characteristics]. Tupitsyn NN; Baryshnikov AIu; Makhonova LA; Peterson IS; Morozova LF Gematol Transfuziol; 1984 Aug; 29(8):49-54. PubMed ID: 6332760 [No Abstract] [Full Text] [Related]
9. Clinical and biologic features predict a poor prognosis in acute lymphoid leukemias in infants: a Pediatric Oncology Group Study. Crist W; Pullen J; Boyett J; Falletta J; van Eys J; Borowitz M; Jackson J; Dowell B; Frankel L; Quddus F Blood; 1986 Jan; 67(1):135-40. PubMed ID: 2934104 [TBL] [Abstract][Full Text] [Related]
10. The French-American-British (FAB) classification of leukemia. The Pediatric Oncology Group experience with lymphocytic leukemia. van Eys J; Pullen J; Head D; Boyett J; Crist W; Falletta J; Humphrey GB; Jackson J; Riccardi V; Brock B Cancer; 1986 Mar; 57(5):1046-51. PubMed ID: 3484662 [TBL] [Abstract][Full Text] [Related]
11. Comparison of the expression of terminal deoxynucleotidyl transferase and common acute lymphoblastic leukemia antigen in selected hematologic malignancies. Bodner SM; Casavant CH; McHugh TM; Stites DP Diagn Immunol; 1985; 3(3):139-44. PubMed ID: 2932276 [TBL] [Abstract][Full Text] [Related]
12. Morphologic, immunologic and cytogenetic studies in children with acute lymphoblastic leukemia at diagnosis and relapse: a Pediatric Oncology Group study. Abshire TC; Buchanan GR; Jackson JF; Shuster JJ; Brock B; Head D; Behm F; Crist WM; Link M; Borowitz M Leukemia; 1992 May; 6(5):357-62. PubMed ID: 1534389 [TBL] [Abstract][Full Text] [Related]
13. [Surface membrane receptors, differentiation antigens and cytochemical characteristics of blood cells in acute lymphoblastic leukemia in children]. Gluzman DF; Skliarenko LM; Nadgornaia VA; Poludnenko LIu; Sidorenko SP Eksp Onkol; 1987; 9(3):36-9. PubMed ID: 2956083 [TBL] [Abstract][Full Text] [Related]
14. [Heterogeneity of surface characteristics of lymphoid cells altered by malignancy]. Batinić D; Boranić M Lijec Vjesn; 1985 Jul; 107(7):273-7. PubMed ID: 3160902 [No Abstract] [Full Text] [Related]
15. Acute lymphocytic leukemia in childhood: immunologic marker, cytogenetic, and molecular studies. Crist WM; Furman W; Strother D; Pui CH South Med J; 1987 Jul; 80(7):841-7. PubMed ID: 2955521 [TBL] [Abstract][Full Text] [Related]
16. A clinical perspective on cell markers in acute lymphocytic leukemia. Bowman WP; Melvin SL; Aur RJ; Mauer AM Cancer Res; 1981 Nov; 41(11 Pt 2):4794-801. PubMed ID: 6975162 [TBL] [Abstract][Full Text] [Related]
17. Human bone marrow cells positive for terminal deoxynucleotidyl transferase (TdT), HLA-DR, and a T cell marker may represent prothymocytes. van Dongen JJ; Hooijkaas H; Comans-Bitter M; Hählen K; de Klein A; van Zanen GE; van't Veer MB; Abels J; Benner R J Immunol; 1985 Nov; 135(5):3144-50. PubMed ID: 2413114 [TBL] [Abstract][Full Text] [Related]
18. Current management of childhood acute lymphocytic leukemia. Ekert H Indian J Pediatr; 1981; 48(393):491-9. PubMed ID: 7035349 [No Abstract] [Full Text] [Related]
19. Reactivity of acute lymphoblastic leukemia and normal bone marrow cells with the monoclonal anti-B-lymphocyte antibody, anti-Y 29/55. Hirt A; Baumgartner C; Forster HK; Imbach P; Wagner HP Cancer Res; 1983 Sep; 43(9):4483-5. PubMed ID: 6603266 [TBL] [Abstract][Full Text] [Related]
20. [Immunocytological and kinetic characteristics of leukemic cerebrospinal fluid cells in children with neuroleukemia]. Kurmashov VI; Vladimirskaia EB; Grigor'iants LIa Pediatriia; 1987; (8):14-9. PubMed ID: 2960949 [No Abstract] [Full Text] [Related] [Next] [New Search]